文献速递产科

剖宫产后出院后阿片类药物使用预测模型的开发与验证

Development and Validation of a Model to Predict Postdischarge Opioid Use After Cesarean Birth.
PubMed 文献 · Obstet Gynecol · 2022-04-05

前瞻性队列研究纳入459名剖宫产患者,出院时开具30片氢可酮5mg-对乙酰氨基酚325mg,14天后问卷评估出院后阿片类药物使用。三个比例优势模型预测准确性高(一致性指数范围0.74-0.76),最终选择仅含三个电子健康记录预测因子的简化模型。

要点

  • 最终模型仅含三个电子健康记录预测因子:住院期间阿片类药物使用、烟草使用、抑郁或焦虑。
  • 模型预测出院后阿片类药物使用的一致性指数范围为0.74-0.76。
  • 398名有结局测量的参与者出院后使用中位数为8片(四分位距1-18片),23.5%未使用阿片类药物,23.0%使用全部阿片类药物。

核心结论

  • 仅含三个电子健康记录预测因子(住院期间阿片类药物使用、烟草使用、抑郁或焦虑)的模型能准确估计剖宫产后出院后阿片类药物使用,为个体化阿片类药物处方提供了机会。

研究设计与样本

  • 前瞻性队列研究,纳入459名剖宫产患者,术后入组,出院后14天完成疼痛和阿片类药物使用问卷,临床数据从电子健康记录中提取。

主要发现

  • 398名有结局测量的参与者出院后使用中位数为8片(四分位距1-18片),23.5%未使用阿片类药物,23.0%使用全部阿片类药物。
  • 三个模型预测出院后阿片类药物使用的一致性指数范围均为0.74-0.76。
  • 简化模型因预测性能相似且预测因子最少(均来自电子健康记录)被选为最终模型。

临床怎么用

  • 作者认为该模型为剖宫产后个体化阿片类药物处方提供了机会。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To develop and validate a prediction model for postdischarge opioid use in patients undergoing cesarean birth. METHODS: We conducted a prospective cohort study of patients undergoing cesarean birth. Patients were enrolled postoperatively, and they completed pain and opioid use questionnaires 14 days after cesarean birth. Clinical data were abstracted from the electronic health record (EHR). Participants were prescribed 30 tablets of hydrocodone 5 mg-acetaminophen 325 mg at discharge and were queried about postdischarge opioid use. The primary outcome was total morphine milligram equivalents used. We constructed three proportional odds predictive models of postdischarge opioid use: a full model with 34 predictors available before hospital discharge, an EHR model that excluded questionnaire data, and a reduced model. The reduced model used forward selection to sequentially add predictors until 90% of the full model performance was achieved. Predictors were ranked a priori based on data from the literature and prior research. Predictive accuracy was estimated using discrimination (concordance index). RESULTS: Between 2019 and 2020, 459 participants were enrolled and 279 filled the standardized study prescription. Of the 398 with outcome measurements, participants used a median of eight tablets (interquartile range 1-18 tablets) after discharge, 23.5% used no opioids, and 23.0% used all opioids. Each of the models demonstrated high accuracy predicting postdischarge opioid use (concordance index range 0.74-0.76 for all models). We selected the reduced model as our final model given its similar model performance with the fewest number of predictors, all obtained from the EHR (inpatient opioid use, tobacco use, and depression or anxiety). CONCLUSION: A model with three predictors readily found in the EHR-inpatient opioid use, tobacco use, and depression or anxiety-accurately estimated postdischarge opioid use. This represents an opportunity for individualizing opioid prescriptions after cesarean birth.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Osmundson SS, Halvorson A, Graves KN, et al. Development and Validation of a Model to Predict Postdischarge Opioid Use After Cesarean Birth. Obstet Gynecol. 2022. PMID: 35576347. doi:10.1097/AOG.0000000000004759

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。